Diaphragmatic Myofascial Release Techinque on Chest Expansion and Heart Rate in Patients Having Thoracic Kyphosis

September 1, 2025 updated by: Riphah International University

Effects of Diaphragmatic Myofascial Release on Chest Expansion and Heart Rate in Patients With Thoracic Kyphosis

The air of this RCT is to evaluate the effects Diaphragmatic Myofascial Release technique on chest expansion and heart rate in patients with thoracic kyphosis

Study Overview

Detailed Description

This study focus on diaphragmatic release technique along with conventional therapy is more effective in improving chest expansion and with im-proved chest expansion, heart rate and blood pressure is also improved because tho-racic kyphosis impacts the way of heart and lung function creating stress response and increasing heart rate and blood pressure. Lung capacity is also reduced in indi-viduals with thoracic kyphosis. Postural alterations of thoracic spine result in im-paired chest expansion and length tension curve of diaphragm.

Study Type

Interventional

Enrollment (Actual)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Federal Capital
      • Islamabad, Federal Capital, Pakistan, 45750
        • Riphah International University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Both male and females
  • age 18-40 years
  • patients who consented to the purposes of this study and participated voluntarily.
  • patients with thoracic kyphosis ≥40

Exclusion Criteria:

  • Participant failing to fall in this category would be excluded of the study.
  • Vertebrobasilar insufficiency, rib fracture, rib dislocation and/or signs of serious pathology (e.g., malignancy, inflammatory disorder, infection);
  • History of cervical spine surgery in previous 12 months
  • Signs of cervical radiculopathy or myelopathy; and vascular syndromes such as basilar insufficiency.
  • Patients with diagnosed any respiratory condition.
  • Patient diagnosed with hypertension or taking any medication

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Diaphragmatic Myofascial release
Myofascial release of the diaphragm is an intervention intended to indirectly stretch the diaphragm muscle fibers to reduce muscle tension, normalize fiber length, and promote the efficiency of muscle contraction.
To release the diaphragm, the patient was positioned in the supine position. The therapist stood at the head of the patient. The therapist made manual contact bilaterally under the costal cartilages of the lower ribs (7th to 10th) with hypothenar regions of the hands and last three fingers. During the patient's inspiration, the therapist was gently pulling the points of hands contacts toward the head and slightly laterally, while elevating the ribs simultaneously. During exhalation, the therapist deepened hand contacts towards the inner costal margins Exercise Program (3 sets of 12 reps) Strengthening deep cervical flexors Strengthening shoulder retractors Stretching Cervical Extensors Stretching Pectoralis Muscle
Active Comparator: Traditional Physical therapy
Strengthening Deep Cervical Flexors Strengthening Shoulder Retractors Stretch Cervical Extensors Stretch Pectoralis Muscle

The exercise program included the strengthening of the deep cervical flexor and shoulder retractor muscles and also stretching of the pectoralis and cervical extensor muscles.

(3 sets of 12 repetitions) Strengthening Deep Cervical Flexors Lying chin tuck Lying chin tuck with head lift. Strengthening Shoulder Retractors Standing shoulder pull back with elastic Shoulder pull back with weight Stretch Cervical Extensors Chin drop Stretch Pectoralis Muscle Bilateral Pectoral stretch

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Chest Expansion
Time Frame: 3rd week
Diaphragm is facially and mechanically attached to thoracic spine, so releasing tension in diaphragmatic muscles will improve biomechanics, resulting in greater chest expansion and improving heart rate.
3rd week
Heart Rate
Time Frame: 3rd week
Diaphragm a thin, flat muscle that separates the thoracic and abdominal cavity, is the primary muscle of respiration, which plays significant role in breathing and physiological regulation. Hyper kyphosis negatively affects chest expansion and heartrate by causing limited mobility in thoracic cage. Diaphragm is facially and mechanically attached to thoracic spine, so releasing tension in diaphragmatic muscles will improve biomechanics, resulting in greater chest expansion and improving heart rate
3rd week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Thoracic Kyphosis
Time Frame: 3rd week
Kyphosis is an abnormal convex curvature in thoracic spine, certain factors such as neuromuscular disorders, congenital anomalies and positional difficulties trigger development of kyphotic posture. Thoracic kyphosis affects the physiological and anatomical feature of the human body
3rd week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Shamaila Yaqub, MS OMPT, Riphah International University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 16, 2024

Primary Completion (Actual)

December 15, 2024

Study Completion (Actual)

December 15, 2024

Study Registration Dates

First Submitted

October 23, 2024

First Submitted That Met QC Criteria

October 23, 2024

First Posted (Actual)

October 24, 2024

Study Record Updates

Last Update Posted (Estimated)

September 3, 2025

Last Update Submitted That Met QC Criteria

September 1, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • REC/014375 Ayeza Naser

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe